03949nam a22005775i 4500 978-981-97-7380-0 DE-He213 20251030113247.0 cr nn 008mamaa 241026s2024 si | s |||| 0|eng d 9789819773800 978-981-97-7380-0 10.1007/978-981-97-7380-0 doi RM300-666 MMG bicssc MED071000 bisacsh MKG thema Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers [electronic resource] : A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview / edited by Mukesh Nandave. 1st ed. 2024. Singapore : Springer Nature Singapore : Imprint: Springer, 2024. XIV, 602 p. 25 illus. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Chapter 1_ Introduction of the renin-angiotensin-aldosterone system (RAAS) -- Chapter 2_ Role of anti-hypertensive agents in cardiovascular disorders -- Chapter 3_ (ACE) Angiotensin-converting enzyme inhibitors: Preferred RAAS inhibitor in high-risk patients as compared to angiotensin receptor blockers (ARBs) -- Chapter 4_ Role of (ACE) angiotensin-converting enzyme inhibitors in transforming renin–angiotensin system -- Chapter 5_ The effect of (ACE) Angiotensin-converting enzyme inhibitors vs angiotensin receptor blockers on insulin resistance in hypertensive patients -- Chapter 6_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure -- Chapter 7_ Immunomodulator activity of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients -- Chapter 8_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peripheral artery disease -- Chapter 9_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in covid-19 patients -- Chapter 10_ Recent trends in the management of hypertension through RAAS inhibition. The auto-summaries have been generated by a recursive clustering algorithm via the Dimensions Auto-summarizer by Digital Science handled by Subject Matter Experts and the editor(s) of this book. The editor(s) of this book selected which SN content should be auto-summarized and decided its order of appearance. Please be aware that these are extractive auto-summaries, which consist of original sentences, but are not representative of its original paper, since we do not show the full length of the publication. Please note that only published SN content is represented here, and that machine-generated books are still at an experimental stage. Pharmacology. 67844 Pharmacovigilance. 74275 Medicine Research. 62598 Biology Research. 65629 Clinical biochemistry. 67825 Therapeutics. 70087 Pharmacology. 67844 Drug Safety and Pharmacovigilance. 74276 Biomedical Research. 65633 Medical Biochemistry. 67828 Therapeutics. 70087 Nandave, Mukesh. editor. edt http://id.loc.gov/vocabulary/relators/edt 74724 SpringerLink (Online service) Springer Nature eBook Printed edition: 9789819773794 Printed edition: 9789819773817 Printed edition: 9789819773824 https://doi.org/10.1007/978-981-97-7380-0 ZDB-2-SME ZDB-2-SXM 64518 64518